Benchling

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Webinar explores how AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Americas Session – Your infinite program team: How AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

Webinar date:
Supported by Benchling
#Featured Webinars #Webinars

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Europe Session – Your infinite program team: How AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

Webinar date:
Supported by Benchling
#Featured Webinars #Webinars

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

New webinar – Your infinite program team: How AI agents are accelerating R&D

R&D teams don’t need another chatbot. They need a team that can act on their behalf, guided by the scientists who know the science best. The future of R&D removes the toil of day-to-day work and connects the data scattered across your systems and teams. In this webinar, taking place… Read More

#News

#Artificial intelligence (AI) #Benchling #Collaboration #Moderna

Moderna and Benchling collaborate on AI-driven research

Moderna and Benchling have extended their collaboration into a broader rollout across the company’s research organisation.   The expansion will bring hundreds of Moderna’s scientists onto a unified, AI-ready research and development digital platform designed to accelerate discovery and innovation.  “Moderna was built on the belief… Read More

#Business & Investment #News

#Artificial intelligence (AI) #Benchling #Drug discovery #Lab automation #Proscia #Webinar

Register now: AI and lab automation webinar

Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn… Read More

#News

AI and lab automation
#Artificial intelligence (AI) #Benchling #Drug discovery #Lab automation #Proscia #Webinar

Key benefits and latest innovations in AI and lab automation

Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn… Read More

#News

#Artificial intelligence (AI) #Benchling #Drug discovery #Lab automation #Proscia #Webinar

Webinar on benefits and innovation in AI and lab automation

Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn… Read More

#News

#Artificial intelligence (AI) #Benchling #Drug discovery #Lab automation #Proscia #Webinar

The benefits and innovations in AI and lab automation

Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn… Read More

#News

Future lab, AI and digital data
#Artificial intelligence (AI) #Benchling #Drug discovery #Lab automation #Proscia #Webinar

Webinar: Key benefits and latest innovations in AI and lab automation

Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn… Read More

#News

Artificial intelligence
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Benchling #Cancer research #Drug discovery #Machine learning #Rare disease

Latest eBook: AI and drug development

The latest eBook by DDW is out now. This 28-page eBook, sponsored by Benchling, examines the ways in which artificial intelligence and machine learning are expediting drug discovery efforts. Download this exclusive eBook to learn more about: The latest advancements in artificial intelligence… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Benchling #Cancer research #Drug discovery #Machine learning #Rare disease

AI and drug development: Using AI and machine learning to expedite drug discovery

This latest eBook sponsored by Benchling features insight on how artificial intelligence is helping advance drug discovery efforts. Download this exclusive eBook to learn more about: The latest advancements in artificial intelligence How machine learning is being used across cancer research Why AI is critical to solving challenges in drug… Read More

#DDW eBooks #Intelligence

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Benchling #Data standardisation #Machine learning

Want to be ready to implement AI and ML in biotech? Start with your data

This article is sponsored by Benchling. “What’s the single most important factor when building a machine learning model? Data! Having the right data, and an understanding of the uncertainty in that data often makes the difference between useful and useless models,” said Pat Walters, Chief Data… Read More

#News